Where I see patients (5)
Selected research
-
Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
-
Fecal microbiota changes in people with cystic fibrosis after 6 months of elexacaftor/tezacaftor/ivacaftor: Findings from the promise study.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
-
Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Contact me
Translation, please
We have interpreters for Cantonese, Mandarin, Spanish, Russian, American Sign Language and more.
Request an interpreter
